基尿素在儿科咳中的治疗作用: 一项系统性审查
Abdullah H Alhamoud1,2,3, Mohammed Y Suhaqi1,4, Qasem A Arishi5
1Department of Pediatrics, King Fahad Central Hospital, Jazan Health Cluster, Ministry of Health, Jazan, Saudi Arabia.
Sultan Qaboos University medical journal
|January 15, 2026
概括
基尿素在患有百日咳的重症婴儿中减少白细胞的潜力,可能避免侵入性手术. 然而,证据有限,需要进一步的研究来确认安全性和有效性.
科学领域:
- 儿科重症监护医学 儿科重症监护医学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 百日咳,特别是在婴儿中,可以导致严重的并发症,包括高白细胞计数 (白血球症).
- 在儿科重症监护中严重白细胞瘤的当前管理可能涉及侵入性白细胞减少程序.
- 需要有效和不那么侵入性的治疗方案来管理儿科关键性百日咳的白血病减少.
研究的目的:
- 系统地审查现有证据,关于使用氧尿素用于小儿重症百日咳的白血病减轻.
- 评估氧尿素作为这种患者群体的辅助治疗的潜在疗效和安全性.
主要方法:
- 系统审查已发表的文献,包括案例报告和案例系列.
- 对与白细胞减少和患者存活率有关的报告结果的分析.
- 评估安全监测和随访数据,如果有.
主要成果:
- 在报告的儿科关键性百日咳病例中,氨酸与白细胞减少有关.
- 在接受氧尿素治疗的患者中观察到短期生存.
- 该药物可能为传统的白血病减轻手术提供一种不那么侵入性的替代方案,特别是在资源有限的环境中.
结论:
- 氧尿素是一种潜在的有前途的药理选择,用于儿科关键性百日咳的白血病减少.
- 目前的证据仅限于来自不受控制的研究的低确定性数据,需要谨慎.
- 进一步严格的多中心研究和随机对照试验对于验证基尿素的疗效和安全性概况至关重要.
相关概念视频
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
964
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
964
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Drugs Used in Upper Respiratory Disorders: Overview
626
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
626
Pharmacokinetics in Pediatric Patients: Drug Metabolism
192
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
192
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
242
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
242


